X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
hematology (16) 16
index medicus (16) 16
female (15) 15
male (15) 15
middle aged (15) 15
aged (14) 14
adult (13) 13
young adult (9) 9
treatment outcome (8) 8
adolescent (6) 6
prognosis (6) 6
acute myeloid leukemia (4) 4
aged, 80 and over (4) 4
antibodies, monoclonal - therapeutic use (4) 4
antibodies, monoclonal, humanized (4) 4
classification (4) 4
cytarabine - administration & dosage (4) 4
diagnosis (4) 4
flow cytometry (4) 4
minimal residual disease (4) 4
mutations (4) 4
therapy (4) 4
abridged index medicus (3) 3
acute myeloid-leukemia (3) 3
adults (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
bone marrow (3) 3
flow-cytometry (3) 3
hemoglobinuria, paroxysmal - therapy (3) 3
leukemia, myeloid, acute - diagnosis (3) 3
leukemia, myeloid, acute - genetics (3) 3
leukemia, myeloid, acute - mortality (3) 3
phenotype (3) 3
survival rate (3) 3
transplantation (3) 3
acute myelogenous leukemia (2) 2
analysis (2) 2
animals (2) 2
antineoplastic agents - administration & dosage (2) 2
aplastic-anemia (2) 2
articles (2) 2
blast crisis - drug therapy (2) 2
bone marrow transplantation (2) 2
cd55 antigens - genetics (2) 2
cd55 antigens - immunology (2) 2
cd59 antigens - genetics (2) 2
cd59 antigens - immunology (2) 2
cells (2) 2
clearance (2) 2
cluster analysis (2) 2
colony-stimulating factor (2) 2
combined modality therapy (2) 2
complement (2) 2
cytarabine (2) 2
decay-accelerating factor (2) 2
deficiency (2) 2
disease-free survival (2) 2
diseases of the blood and blood-forming organs (2) 2
eculizumab (2) 2
epidemiology (2) 2
gene-expression (2) 2
hematopoietic stem cells (2) 2
hemoglobinuria, paroxysmal - diagnosis (2) 2
hemoglobinuria, paroxysmal - genetics (2) 2
hemoglobinuria, paroxysmal - immunology (2) 2
hemolysis (2) 2
hemolysis - drug effects (2) 2
idarubicin - administration & dosage (2) 2
immunophenotyping (2) 2
in-vitro (2) 2
infectious diseases (2) 2
italy - epidemiology (2) 2
journal of blood medicine (2) 2
leukemia, myeloid, acute - drug therapy (2) 2
leukemia, myeloid, acute - pathology (2) 2
leukocyte count (2) 2
medical laboratory technology (2) 2
medicine & public health (2) 2
mice (2) 2
monoclonal antibodies (2) 2
mutation (2) 2
nuclear proteins - genetics (2) 2
paroxysmal nocturnal hemoglobinuria (2) 2
pathology (2) 2
patients (2) 2
pig-a gene (2) 2
predictive value of tests (2) 2
predicts (2) 2
prospective studies (2) 2
proteins (2) 2
recommendations (2) 2
red-cells (2) 2
remission induction (2) 2
remission induction - methods (2) 2
settore med/15 - malattie del sangue (2) 2
stem cell transplantation (2) 2
stem cells (2) 2
survival analysis (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Hematology, ISSN 0925-5710, 8/2006, Volume 84, Issue 2, pp. 104 - 112
The unique feature of paroxysmal nocturnal hemoglobinuria (PNH), a chronic disease with severe hemolytic anemia, is the presence of a population of blood cells... 
Autoimmunity | Medicine & Public Health | Hematology | Anemia | Eculizumab | Oncology | Clonal selection | Paroxysmal nocturnal hemoglobinuria | Complement | paroxysmal nocturnal hemoglobinuria | MINOR POPULATION | RECOMBINANT-HUMAN-ERYTHROPOIETIN | eculizumab | RED-CELLS | anemia | autoimmunity | PLASMINOGEN-ACTIVATOR | INTERFERON-GAMMA | GENE-EXPRESSION | FLOW-CYTOMETRY | complement | HEMATOLOGY | clonal selection | APLASTIC-ANEMIA | T-CELLS | BLOOD-CELLS | Complement C5 - genetics | Hemolysis - drug effects | CD59 Antigens - immunology | Humans | CD55 Antigens - genetics | Hematopoietic Stem Cells - pathology | Antibodies, Monoclonal - therapeutic use | Hemoglobinuria, Paroxysmal - pathology | Killer Cells, Natural - pathology | Complement Activation - immunology | Hemolysis - immunology | Hemoglobinuria, Paroxysmal - immunology | Antibodies, Monoclonal, Humanized | Hematopoietic Stem Cells - immunology | Complement C5 - immunology | Killer Cells, Natural - immunology | T-Lymphocytes - pathology | CD55 Antigens - immunology | Hemoglobinuria, Paroxysmal - diagnosis | Protease Inhibitors - therapeutic use | Complement Activation - drug effects | Hemolysis - genetics | Hemoglobinuria, Paroxysmal - genetics | CD59 Antigens - genetics | Complement Activation - genetics | Animals | T-Lymphocytes - immunology | Mice | Hemoglobinuria, Paroxysmal - therapy | Complement C5 - antagonists & inhibitors | Proteins | Medical research | Chronic diseases | Monoclonal antibodies | Medicine, Experimental | College teachers | Hematopoietic stem cells
Journal Article
Blood, ISSN 0006-4971, 2009, Volume 113, Issue 18, pp. 4153 - 4162
Journal Article
Haematologica, ISSN 0390-6078, 05/2010, Volume 95, Issue 5, pp. 833 - 836
Journal Article
Journal Article
Journal of blood medicine, ISSN 1179-2736, 2019, Volume 10, pp. 21 - 27
We conducted a retrospective study to evaluate the efficacy and related costs of using two different molecules of granulocyte-colony stimulating factor (G-CSF)... 
Biological products | Transplants & implants | Hematology | Neutrophils | Breast cancer | Hospitalization | Patients | Cancer therapies | Chemotherapy | Hospitals | Granulocytes | Stem cells | Lymphomas | Drug dosages | Neutropenia | filgrastim | Lenograstim | neutropenia | cost | biosimilar
Journal Article
Cytometry Part B: Clinical Cytometry, ISSN 1552-4949, 09/2014, Volume 86, Issue 5, pp. 340 - 349
Background In acute myeloid leukemia (AML), CXCR4 expression has been correlated with leukocytosis and prognosis. Methods We quantified CXCR4 expression by... 
CXCR4 | NPM1 | acute myeloid leukemia | prognosis | immunophenotype | CHEMOKINE RECEPTOR CXCR4 | STEM-CELL NICHE | CLASSIFICATION | ADVERSE | PATHOLOGY | OVEREXPRESSION | MUTATIONS | MEDICAL LABORATORY TECHNOLOGY
Journal Article
Journal of Blood Medicine, ISSN 1179-2736, 02/2019, Volume 10, pp. 69 - 70
Innocenti R, Rigacci L, Restelli U, et al J Blood Med. 2019;10:21-27. On page 24, Figure 2, the key for the figure was incorrect. Read the original article 
Journal Article
Haematologica, ISSN 0390-6078, 02/2017, Volume 102, Issue 3, pp. 529 - 540
Journal Article
Journal Article
Journal Article
Cytometry Part B: Clinical Cytometry, ISSN 1552-4949, 03/2013, Volume 84B, Issue 2, pp. 71 - 81
Journal Article